Solesence(SLSN.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Solesence
SLSN.US
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin health products, such as sunscreens and daily care products; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc.
492.32 B
SLSN.USMarket value -Rank by Market Cap -/-

Financial Score

26/01/2026 Update
B
Specialty ChemicalsIndustry
Industry Ranking10/48
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE6.60%C
    • Profit Margin1.72%C
    • Gross Margin23.09%D
  • Growth ScoreB
    • Revenue YoY30.04%A
    • Net Profit YoY-59.89%D
    • Total Assets YoY12.36%B
    • Net Assets YoY13.57%B
  • Cash ScoreA
    • Cash Flow Margin5813.66%A
    • OCF YoY30.04%A
  • Operating ScoreA
    • Turnover1.22A
  • Debt ScoreD
    • Gearing Ratio68.09%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Solesence (NASDAQ:SLSN) Stock Price Up 2% - Time to Buy?

    Solesence (NASDAQ:SLSN) saw a 2% increase in stock price, trading at $1.54. Despite this rise, analysts maintain a "sell" rating, with a consensus rating of "sell". The company reported a quarterly loss of $0.02 per share and revenue of $14.60 million. Insider activity includes a director purchasing shares, increasing their stake. Institutional investors hold 70.22% of the stock. Solesence specializes in engineered materials for personal care and industrial applications. Analysts suggest considering other stocks over Solesence for investment.

    Market Beat·
    US
    SLSN
    +2.03%
    Market Beat·
    US
    SLSN
    +2.03%

    Director Janet R. Whitmore Acquires Common Shares of Solesence Inc

    Janet R. Whitmore, Director at Solesence Inc., has acquired common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. Solesence Inc. is responsible for the original content published via EDGAR on December 30, 2025.

    Reuters·
    US
    SLSN
    +2.03%
    Reuters·
    US
    SLSN
    +2.03%

    Director R. Janet Whitmore Acquires Common Shares of Solesence Inc

    R. Janet Whitmore, a Director at Solesence Inc., has acquired common shares of the company. This information was reported through EDGAR by Solesence Inc. on December 11, 2025. The news is generated by Public Technologies using AI and is not financial advice.

    Reuters·
    US
    SLSN
    +2.03%
    Reuters·
    US
    SLSN
    +2.03%

    Solesence Inc. Grants $366,912 Severance and Accelerated Option Vesting to Former CEO Jess Jankowski

    Solesence Inc. has agreed to a severance package for former CEO Jess Jankowski, including $366,912 and accelerated option vesting. The company will also cover his health insurance premiums through COBRA during the severance period. This information was published via EDGAR by Solesence Inc. on December 03, 2025.

    Reuters·
    US
    SLSN
    +2.03%
    Reuters·
    US
    SLSN
    +2.03%

    Solesence Appoints Kevin Cureton to Board as Jess Jankowski Retires

    Solesence Inc. announced the retirement of Jess Jankowski from its Board of Directors, effective November 21, 2025. Kevin Cureton, CEO and President, has been appointed as a Class III Director for the remainder of Jankowski's term. This change was disclosed via EDGAR by Solesence Inc.

    Reuters·
    US
    SLSN
    +2.03%
    Reuters·
    US
    SLSN
    +2.03%
    © 2026 Longbridge｜Disclaimer